Zika virus infection future or investigational therapies
Zika virus infection Microchapters |
Diagnosis |
Treatment |
Case Studies |
Zika virus infection future or investigational therapies On the Web |
American Roentgen Ray Society Images of Zika virus infection future or investigational therapies |
FDA on Zika virus infection future or investigational therapies |
CDC on Zika virus infection future or investigational therapies |
Zika virus infection future or investigational therapies in the news |
Blogs on Zika virus infection future or investigational therapies |
Risk calculators and risk factors for Zika virus infection future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Nate Michalak, B.A.
Overview
There is currently no vaccine in advanced development to prevent Zika virus infection.
Future or Investigational Therapies
- There is currently no vaccine in advanced development to prevent Zika virus infection.
- It is unknown if vaccines against other flaviviruses are effective against Zika virus. The efficacy and safety of vaccines currently under development against Chikungunya virus are being studied in pre-clinical experiments for Zika virus.[2]
- In February 2016, Sanofi, Pfizer, Johnson and Johnson, Merck,and Takeda announced the launching of projects to develop vaccines against Zika virus using either new technologies or existing vaccines.[3][4]
- Recent animal studies have shown that human monoclonal antibodies against Zika virus envelope (E) protein, isolated from individuals with prior Zika virus infection, reduce tissue pathology, maternal-fetal transmission, and mortality when injected in mice.[1]
References
- ↑ Sapparapu G, Fernandez E, Kose N, Cao B, Fox JM, Bombardi RG; et al. (2016). "Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice". Nature. doi:10.1038/nature20564. PMID 27819683.